SHANGHAI, Jan. 28, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, has stepped up its efforts in enabling the development of...
from PR Newswire: https://ift.tt/2RyKwoA
No comments:
Post a Comment